Trial intelligence / Profile preview

THR-4109 for weight loss in obese subjects

NCT00485017Phase 2Completed

Sponsor
Theracos, Inc.
Start
Aug 2007
Primary completion
Jun 2008
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of sertraline + telenzepine in obesity, sponsored by Theracos, Inc.. Started Aug 2007; status: completed.

02

Drugs

sertraline + telenzepine
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00485017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00485017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call